H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Agent-enhanced CT scan plays a supporting role in diagnosing severe cases of H1N1 flu virus

Agent-enhanced CT scan plays a supporting role in diagnosing severe cases of H1N1 flu virus

Life Technologies reports fourth-quarter and fiscal year results ended December 31, 2009

Life Technologies reports fourth-quarter and fiscal year results ended December 31, 2009

National contest invites teens and teachers to participate in flu prevention campaign

National contest invites teens and teachers to participate in flu prevention campaign

Sinovac prices public offering at $5.75 per common share

Sinovac prices public offering at $5.75 per common share

African vaccine maker plans to increase production capacity sevenfold by 2013

African vaccine maker plans to increase production capacity sevenfold by 2013

WHO addresses handling of H1N1 at Council of Europe meeting

WHO addresses handling of H1N1 at Council of Europe meeting

MBL generates human monoclonal antibodies against pandemic A type influenza virus

MBL generates human monoclonal antibodies against pandemic A type influenza virus

Recipients of the 2010 Media Awards for Health Reporting announced

Recipients of the 2010 Media Awards for Health Reporting announced

WHO Director-General highlights global health gains, challenges at executive board meeting

WHO Director-General highlights global health gains, challenges at executive board meeting

Health care providers play a critical role in H1N1 vaccinations

Health care providers play a critical role in H1N1 vaccinations

WHO rejects accusations it mishandled H1N1, updates worldwide stats

WHO rejects accusations it mishandled H1N1, updates worldwide stats

Department of Health to continue H1N1 vaccination clinics every Saturday in Pennsylvania

Department of Health to continue H1N1 vaccination clinics every Saturday in Pennsylvania

Opinion: Haiti relief; WHO response to H1N1

Opinion: Haiti relief; WHO response to H1N1

BioSyent Pharma receives exclusive rights to manufacture and market Virsani sanitizer in Canada and U.S.

BioSyent Pharma receives exclusive rights to manufacture and market Virsani sanitizer in Canada and U.S.

BioTech Medics begins creating TV and radio commercials for SHBAN Alcohol Free Antiseptic Hand Sanitizer

BioTech Medics begins creating TV and radio commercials for SHBAN Alcohol Free Antiseptic Hand Sanitizer

New study concerning the severity of H1N1 influenza published in CMAJ

New study concerning the severity of H1N1 influenza published in CMAJ

Clorox urges organizations to equip with flu prevention educational tools to prevent virus spread

Clorox urges organizations to equip with flu prevention educational tools to prevent virus spread

BC Centre for Disease Control launches influenza genome sequencing project

BC Centre for Disease Control launches influenza genome sequencing project

Ordinary face masks and hand hygiene can reduce transmission of influenza-like illness

Ordinary face masks and hand hygiene can reduce transmission of influenza-like illness

Meridian Bioscience announces record first-quarter net sales of $42.5M

Meridian Bioscience announces record first-quarter net sales of $42.5M

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.